CANF
Can-Fite BioPharma
CANF
CANF
13 hedge funds and large institutions have $186K invested in Can-Fite BioPharma in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
AC
1
Armistice Capital
New York
|
$0 |
2 |
2
Morgan Stanley
New York
|
$52.8K |
3 |
TSS
3
Two Sigma Securities
New York
|
$31.5K |
4 |
4
Osaic Holdings
Scottsdale,
Arizona
|
$293 |